Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.

Blood - 4 May 2017

Montalban-Bravo Guillermo, Benton Christopher B, Wang Sa A, Ravandi Farhad, Kadia Tapan, Cortes Jorge, Daver Naval, Takahashi Koichi, DiNardo Courtney, Jabbour Elias, Borthakur Gautam, Konopleva Marina, Pierce Sherry, Bueso-Ramos Carlos, Patel Keyur, Kornblau Steven, Kantarjian Hagop, Young Ken H, Garcia-Manero Guillermo, Andreeff Michael

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Leukemia, Erythroblastic, Acute

Share to Mutation

Share to Survival Rate

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 28246192
DOI: 10.1182/blood-2016-11-749903
PMCID: PMC5418636

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.PMID 28246192Read ↗

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases.Semantic proximity Read ↗

Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy.Semantic proximity Read ↗

Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.Semantic proximity Read ↗

An unusual case of pure erythroid leukemia with normal karyotype and NPM1 mutation.Semantic proximity Read ↗

De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.Semantic proximity Read ↗

p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell.Semantic proximity Read ↗

A rare de novo pure erythroid leukemia with JAK2 R683S mutation.Semantic proximity Read ↗

Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.Semantic proximity Read ↗

TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.Semantic proximity Read ↗

Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS.Semantic proximity Read ↗

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.Semantic proximity Read ↗

RARE CASE OF PRIMARY AML WITH TP53 DELETIONSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.